Posts

Showing posts with the label Pharma

Pharmaceutical Company Business Strategies

Image
Pharmaceutical Company Business Strategies What’s the secret behind successes? For one, the company operates in niche formulations ( chronic) segments such as psychiatry, cardiovascular, gastroenterology and neurology. While most of the top Indian companies have focused on antibiotics and anti–invectives ( acute ), The bases of marketing strategies can be best described in these two models in both acute and chronic segments:   (i) Super Core Model involving the search for, and distribution of a small number of drugs from Chronic Threapy Area that achieve substantial global sales. The success of this model depends on achieving large returns from a small number of drugs in order to pay for the high cost of the drug discovery and development process for a large number of patients. Total revenues are highly dependent on sales from a small number of drugs. This model incorporates highly specialized approach in the entire manner. Initially the competition is s...

Recent trends of Pharmaceutical Industry

Image
Recent trends of Pharmaceutical Industry While many pharmaceutical companies have successfully deployed a plethora of strategies to target the various customer types, recent business and customer trends are creating new challenges and opportunities for increasing profitability. In the pharmaceutical and healthcare industries, a complex web of decision-makers determines the nature of the transaction (prescription) for which direct customer (doctor) of the pharma industry is responsible. Essentially, the end-user (patient) consumes a product and pays the cost. Use of medical representatives for marketing products to physicians and to exert some influence over others in the hierarchy of decision-makers has been a time-tested tradition. Typically, salesforce expense comprises an estimated 15 percent to 20 percent of annual product revenues, the largest line item on the balance sheet. Despite this other expense, the industry is still plagued with some very serious strategic and operational ...